OUR PATHFINDERS FUND FOR LEADERS IN CANADIAN HEALTH SCIENCE RESEARCH

GlaxoSmithKline’s $22 million Pathfinders Fund for Leaders in Canadian Health Science Research was established to help Canada become a world leader in research and development (R&D). The Pathfinders Fund encourages health science research and fosters innovation in Canadian medical schools

Goals of The Fund

• Promote excellence in Canadian health science research, helping to establish Canada as a world leader in R&D.
• Provide opportunities for attracting and retaining top Canadian researchers and scientists to conduct their important discovery work in Canada.
• Fund research that promises to meet the health-care needs of Canadians.

Pathfinders Partnerships

• $1.75 million for an endowed Chair in Virology at the University of Alberta's Faculty of Medicine and Dentistry
• $1.25 million endowment for the GSK Chair in Airway Inflammation at the University of Alberta
• $1.25 million endowment to establish the GSK Professorship in Inflammatory Lung Disease at the University of Calgary
  
  
• $1 million endowment for Chair in Structural Biology at the University of Saskatchewan.
• $1 million endowed Chair in Pharmaceutics at the University of Toronto
• $1 million endowed for the Chair in Pediatric Asthma to the Firestone Institute of Respiratory Health and McMaster University in Hamilton, Ontario
• $500,000 contribution for the Dr. J. David Grimes Research Chair at the University of Ottawa
• $500,000 for an endowed research Chair of Gastroenterology at McMaster University in Hamilton, Ontario